|
Re: Finance
|
5
|
Resverlogix Corp.
|
Feb 06, 2021 05:06PM
|
|
Re: BeardownAZ
|
5
|
Resverlogix Corp.
|
Jan 18, 2023 11:27AM
|
|
Re: PNAS
|
5
|
Resverlogix Corp.
|
Jan 10, 2021 11:32AM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 03:16PM
|
|
starting to think we only have 200-400 shareholders/partner...
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 09:52AM
|
|
BTD?
|
5
|
Resverlogix Corp.
|
Oct 06, 2020 10:25AM
|
|
Re: I believe the big/long wait
|
5
|
Resverlogix Corp.
|
Aug 23, 2023 11:00AM
|
|
Re: PFE "is only the start of the spending spree that the company has planned"maybe,just maybe
|
5
|
Resverlogix Corp.
|
May 10, 2022 10:48PM
|
|
Re: IR
|
5
|
Resverlogix Corp.
|
Jan 18, 2023 01:14PM
|
|
Re: Hind sight is 20/20....
|
5
|
Resverlogix Corp.
|
Jun 19, 2020 11:12AM
|
|
Re: AHA 2020
|
5
|
Resverlogix Corp.
|
Sep 17, 2020 01:37PM
|
|
Re: looking at the sp & volumes of both rv & zen
|
5
|
Resverlogix Corp.
|
May 03, 2021 11:00AM
|
|
Re: ORI Fund
|
5
|
Resverlogix Corp.
|
Jun 08, 2020 03:53PM
|
|
no web cast - from IR
|
5
|
Zenith Epigenetics
|
Oct 25, 2022 11:33AM
|
|
when Don said this might slide into April
|
5
|
Resverlogix Corp.
|
Mar 29, 2021 06:48PM
|
|
Hepalink continues to set new 52 week lows..
|
5
|
Resverlogix Corp.
|
Apr 11, 2022 10:51AM
|
|
Type C meeting with the FDA is scheduled for August -IR response
|
5
|
Resverlogix Corp.
|
Jul 05, 2022 02:47PM
|
|
Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
5
|
Resverlogix Corp.
|
Mar 15, 2021 10:44AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
5
|
Resverlogix Corp.
|
Jun 15, 2020 09:28AM
|
|
Re: RESVERLOGIX CORP WTS 2021
|
5
|
Resverlogix Corp.
|
May 11, 2021 04:00PM
|
